[HTML][HTML] Waging war against extended spectrum Beta lactamase and metallobetalactamase producing pathogens-novel adjuvant antimicrobial agent cse1034-an …

M Sahu, S Sanjith, P Bhalekar… - Journal of clinical and …, 2014 - ncbi.nlm.nih.gov
Preamble: In the visage of multidrug resistance among gram negative bacilli, we look
forward to carbapenem group of drugs as empiric choice in seriously ill patients. However …

[HTML][HTML] A comparative in vitro sensitivity study of “Ceftriaxone–Sulbactam–EDTA” and various antibiotics against Gram-negative bacterial isolates from intensive care …

S Singh, C Sahu, SS Patel, A Singh… - Indian Journal of …, 2020 - ncbi.nlm.nih.gov
Materials and methods Bacterial isolates cultured from various clinical samples from all ICUs
for a period of 9 months were evaluated. Bacterial identification was performed by matrix …

Prevalence and Susceptibility Analysis of Gram Negative Pathogens in Super Specialty Tertiary Care Centers, Pune in India from January 2018-January 2019

KB Satras - Microbiology Research Journal …, 2019 - classical.academiceprints.com
Background and Objective: The encumbrance of antimicrobial resistance worldwide is
substantive and likely to rise without any appropriate treatment which has enhanced the …

In vitro susceptibilities of clinical isolates of Escherichia coli and Klebsiella species to CSE1034 and other β-lactams

M Chaudhary, S Kumar, A Payasi - The Journal of Antibiotics, 2013 - nature.com
Infections are becoming difficult to treat with commonly used antibiotics when caused by
extended spectrum β-lactamase (ESBL)-and metallo-β-lactamase (MBL)-producing …

[PDF][PDF] Synergy of a novel antibiotic adjuvant entity against multi drug resistant enterobacteriaceae

M Chaudhary, A Payasi - American Journal of Infectious Diseases, 2013 - academia.edu
In the present investigation, we investigated the in vitro interaction of ceftriaxone plus
sulbactam with disodium edetate, a Non Antibiotic Adjuvant (NAA) against selected clinical …

Comparative in vitro Activities of Different Antibiotics against Clinical Isolates of Gram-negative Bacilli

SH Jain, P Joshi - Journal of Advances in Medicine and …, 2019 - journal.send2sub.com
Objective: The local anti-microbial susceptibility profile plays a very critical role in guiding
clinicians to choose the appropriate empiric therapies. This study was conducted to assess …

[PDF][PDF] In Vitro Antimicrobial Susceptibility of Ceftriaxone Sulbactam EDTA (CSE 1034) And Other Β Lactam/Β Lactamase Inhibitors And Carbapenems Against …

S Nema, P Nema, K Mehdi, K Tripathi, VK Ramnani - academia.edu
Emergence of multidrug resistance among enterobacteriaceae has limited the treatment
options. Therefore, it's high time to look ahead for newer possibilities. However, new …

Treatment with CSE-1034 (Elores™) in the Management of Community Acquired Pneumonia Due to Multi Drug Resistant Pseudomonas aeruginosa

A Atreja - International Journal of TROPICAL DISEASE & …, 2016 - eprint.subtopublish.com
Introduction: Community acquired pneumonia (CAP) is one of the important cause of
mortality and morbidity. CAP is defined as an infection of the lung parenchyma that is not …

[PDF][PDF] Evaluation of Cefixime-Clavulanate Combination by Comparative Disk Diffusion Method in Klebsiella pneumoniae Clinical Isolates-An In-Vitro Study

SV Gajul, ST Mohite, SV Kakade… - JOURNAL OF …, 2015 - jkimsu.com
Background: Resistance to cephalosporins due to β-lactamases is a major concern
worldwide. However recent trend is to use β-lactamase inhibitor combinations. Potential …

[PDF][PDF] Evaluation of cefixime-clavulanate combination by comparative disk diffusion method in klebsiella pneumoniae clinical isolates-An in-vitro study.

SS Mangalagi, GSVMSTK SV - 2015 - digitallibrary.bldedu.ac.in
Apr Jun.indd Page 1 JKIMSU, Vol. 4, No. 2, April-June 2015 © Journal of Krishna Institute of
Medical Sciences University 38 Abstract: Background: Resistance to cephalosporins due to …